VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide

Treatment informs FDA approval for emergency expanded access use for GENOSYL® inhaled nitric oxide. Click here to read full press release.

By MCRC|2020-05-14T22:59:25+00:00March 24th, 2020|News|Comments Off